CAJ | 학술논문

宫颈癌是目前全球最常见的妇科恶性肿瘤之一，严重威胁着女性健康。近些年由于宫颈液基细胞学等早期普查手段的广泛应用，宫颈癌的发病率明显下降，但患者趋于年轻化，且局部晚期宫颈癌患者数目增多，因此提高患者的生存率和改善患者的预后也变的越来越重要。新辅助化疗即是在此前提下发展起来的有效治疗方法。
궁경암시목전전구최상견적부과악성종류지일，엄중위협착녀성건강。근사년유우궁경액기세포학등조기보사수단적엄범응용，궁경암적발병솔명현하강，단환자추우년경화，차국부만기궁경암환자수목증다，인차제고환자적생존솔화개선환자적예후야변적월래월중요。신보조화료즉시재차전제하발전기래적유효치료방법。
Cervical cancer is one of the most common gynecologic malignant tumor at present, a serious threat to women's health. In recent years due to the widespread application of liquid based cervical cytology screening method of early, the incidence of cervical cancer is significantly being decreased, but patients tend to be younger, and the number of local y advanced cervical cancer patients is increasing,therefore, improving the survival rate and the prognosis of patients has become increasingly important.Neoadjuvant chemotherapy is an ef ective treatment method based on it.